Copyright
©The Author(s) 2015.
World J Pharmacol. Mar 9, 2015; 4(1): 96-116
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.96
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.96
Figure 3 Barcelona Clinic Liver Cancer staging system and treatment strategy (2011).
HCC: Hepatocellular carcinoma; CLT: Cadaveric liver tansplantation; LDLT: Living donor transplantation; RF: Radiofrequency; PEI: Percutaneous ethanol injection; TACE: Transarterial chemoembolization; PST: Performance status test; PS: Performance status.
- Citation: Cuestas ML, Oubiña JR, Mathet VL. Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement. World J Pharmacol 2015; 4(1): 96-116
- URL: https://www.wjgnet.com/2220-3192/full/v4/i1/96.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i1.96